ArticleScientific reports2021

First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease.

Kiyoharu Fukushima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.